A Phase 2 Study of APX005M in Combination with Concurrent Chemo-radiation as Neoadjuvant Therapy for Resectable Esophageal and Gastroesophageal Junction Cancers

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Esophageal Cancer And Gastroesophageal Cancer
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1) Histologically proven localized squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the esophagus or GE junction. 2) Adequate hematological, renal, and hepatic parameters.

You may not be eligible for this study if the following are true:

  • 1) Any history of or current hematologic malignancy. 2) Major surgery within 4 weeks of first dose of investigational product. 3) Prior or concurrent treatment with any anticancer agent for the same cancer diagnosis.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.